(THE HILL) The Obama administration is abandoning a surprise plan to alter Medicare’s drug coverage after withering criticism from Congress and K Street.
Medicare chief Marilyn Tavenner alerted lawmakers Monday that her agency would not go forward with a proposal to give insurers more leeway to limit the number of drugs they cover for Medicare beneficiaries.
Critics argued that making the change, which was designed to save money, would have hampered seniors’ access to necessary drugs.
Advertisement - story continues below